Cargando…

Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study

Glutathione (GSH) is a major endogenous antioxidant. Several studies have shown GSH redox imbalance and altered GSH levels in Alzheimer’s disease (AD) patients. Early detection is crucial for the outcome of AD. However, whether GSH can serve as a biomarker during the very early-phase of AD, such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chieh-Hsin, Lane, Hsien-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615204/ https://www.ncbi.nlm.nih.gov/pubmed/34829710 http://dx.doi.org/10.3390/antiox10111839

Ejemplares similares

Blood D-Amino Acid Oxidase Levels Increased With Cognitive Decline Among People With Mild Cognitive Impairment: A Two-Year Prospective Study
por: Lin, Chieh-Hsin, et al.
Publicado: (2022)

Risk Factors for Mild Cognitive Impairment (MCI)
por: Loftus, Andrea Mary
Publicado: (2017)

EEG Patterns in Mild Cognitive Impairment (MCI) Patients
por: Baker, Mary, et al.
Publicado: (2008)

The effects of dexmedetomidine on the cognitive function of mild cognitive impairment (MCI) rats
por: Zhou, Qian, et al.
Publicado: (2022)

In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
por: Hessen, Erik, et al.
Publicado: (2019)

The Test Your Memory for Mild Cognitive Impairment (TYM-MCI)
por: Brown, Jeremy M, et al.
Publicado: (2017)

Determinants of Adherence to a “GRADIOR” Computer-Based Cognitive Training Program in People with Mild Cognitive Impairment (MCI) and Mild Dementia
por: Diaz Baquero, Angie A., et al.
Publicado: (2022)

Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
por: Strand, Bjørn Heine, et al.
Publicado: (2018)

Focal white matter disruptions along the cingulum tract explain cognitive decline in amnestic mild cognitive impairment (aMCI)
por: Gozdas, Elveda, et al.
Publicado: (2020)

Cognitive profiles in Mild Cognitive Impairment (MCI) patients associated with Parkinson's disease and cognitive disorders
por: Pistacchi, Michele, et al.
Publicado: (2015)

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2022)

Problems in Classifying Mild Cognitive Impairment (MCI): One or Multiple Syndromes?
por: Díaz-Mardomingo, María del Carmen, et al.
Publicado: (2017)

Screening for Mild Cognitive Impairment: Comparison of “MCI Specific” Screening Instruments
por: O’Caoimh, Rónán, et al.
Publicado: (2016)

Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review
por: Christa Maree Stephan, Blossom, et al.
Publicado: (2013)

Dysfunctional Incidental Olfaction in Mild Cognitive Impairment (MCI): An Electroencephalography (EEG) Study
por: Walla, Peter, et al.
Publicado: (2011)

Mild cognitive impairment (MCI) and dementia in a sample of adults in the city of Bogotá
por: Pedraza, Olga Lucia, et al.
Publicado: (2017)

Memory deficits for facial identity in patients with amnestic mild cognitive impairment (MCI)
por: Savaskan, Egemen, et al.
Publicado: (2018)

Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
por: Jones, Ann J., et al.
Publicado: (2017)

Methodological Designs Applied in the Development of Computer-Based Training Programs for the Cognitive Rehabilitation in People with Mild Cognitive Impairment (MCI) and Mild Dementia. Systematic Review
por: Diaz Baquero, Angie A., et al.
Publicado: (2021)

Genetic Biomarkers on Age-Related Cognitive Decline
por: Lin, Chieh-Hsin, et al.
Publicado: (2017)

The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures
por: Sherman, Dale S., et al.
Publicado: (2017)

Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer’s Disease
por: Guan, Jingjing, et al.
Publicado: (2020)

Episodic Memory in Amnestic Mild Cognitive Impairment (aMCI) and Alzheimer’s Disease Dementia (ADD): Using the “Doors and People” Tool to Differentiate between Early aMCI—Late aMCI—Mild ADD Diagnostic Groups
por: Chatzikostopoulos, Athanasios, et al.
Publicado: (2022)

Association of Anxiety Awareness with Risk Factors of Cognitive Decline in MCI
por: Gigi, Ariela, et al.
Publicado: (2021)

Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research
por: Stephan, Blossom C. M., et al.
Publicado: (2011)

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
por: Risacher, Shannon L., et al.
Publicado: (2013)

Episodic and Semantic Autobiographical Memory in Mild Cognitive Impairment (MCI): A Systematic Review
por: Marselli, Giulia, et al.
Publicado: (2023)

The effect of Mild Cognitive Impairment (MCI) on psychological distress among older adults in Ukraine
por: Avery, Jennifer, et al.
Publicado: (2023)

A Pilot Fuzzy System with Virtual Reality for Mild Cognitive Impairment (MCI) Assessment
por: Liu, Cheng-Li, et al.
Publicado: (2023)

Feasibility and first results of a group program to increase the frequency of cognitively stimulating leisure activities in people with mild cognitive impairment (AKTIVA-MCI)
por: Tesky, Valentina A, et al.
Publicado: (2017)

Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline
por: Ismail, Zahinoor, et al.
Publicado: (2021)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Resilience in Mild Cognitive Impairment (MCI): Examining the Level and the Associations of Resilience with Subjective Wellbeing and Negative Affect in Early and Late-Stage MCI
por: Tsormpatzoudi, Styliani Olympia, et al.
Publicado: (2023)

The effect of statins on rate of cognitive decline in mild cognitive impairment
por: Smith, Kyle B., et al.
Publicado: (2017)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

Virtual Reality (VR)-Based Environmental Enrichment in Older Adults with Mild Cognitive Impairment (MCI) and Mild Dementia
por: Riaz, Waleed, et al.
Publicado: (2021)

Hierarchical Interactions Model for Predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) Conversion
por: Li, Han, et al.
Publicado: (2014)

Parkinson’s Disease–Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge
por: Cammisuli, Davide Maria, et al.
Publicado: (2019)

Medical Health Records-Based Mild Cognitive Impairment (MCI) Prediction for Effective Dementia Care
por: Lim, Soo-Jin, et al.
Publicado: (2021)

New Community and Sociohealth Challenges Arising from the Early Diagnosis of Mild Cognitive Impairment (MCI)
por: López, Carolina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j559d5apvbb06ca3bk90sae7d6